Close Menu

NMPA

The country recently implemented a pilot program issuing licenses to hospitals to run NGS tests for NIPT, PGS/PGD, cancer, and genetic disease.

Chinese regulators approved BGI's clinical laboratories in Shenzhen and Tianjin to conduct high-throughput clinical genetic testing services for cancer.

The NextSeq CN500 sequencer was developed in collaboration with Illumina to offer clinical non-invasive prenatal testing for the Chinese market.

The device is also CE marked for IVD use in Europe and approved in South Korea and Singapore for IVD use.

NEW YORK (GenomeWeb News) – Qiagen said on Monday that its QuantiFeron-TB Gold test has been approved for marketing in China.

NEW YORK (GenomeWeb News) – Life Technologies announced today regulatory approval in China for its Applied Biosystems 3500xL Dx Genetic Analyzer for clinical diagnostic use.
The company also said that 10 assays from its joint venture with Daan Gene have been launched.

NEW YORK (GenomeWeb News) –Amoy Diagnostics today said that China's State Food and Drug Administration has approved the company's EML4-ALK Fusion Gene Detection Kit for marketing in that country.

NEW YORK (GenomeWeb News) – Chinese regulators approved Veridex's CellSearch circulating tumor test for aiding in the diagnosis of women with metastatic breast cancer, Veridex announced on Wednesday.

NEW YORK (GenomeWeb News) – Qiagen announced after the close of the market Wednesday that it has received China State Food and Drug Administration approval for its careHPV Test and instrument platform.

This article has been updated from a version posted Feb. 16 to include comments from an Affymetrix official.
By Justin Petrone

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.